Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BDZL. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102206185A reveals a dual-solvent recrystallization method achieving >99.6% purity and <0.2% impurities for cataract drug intermediates.